NasdaqCM - Delayed Quote USD

Syra Health Corp. (SYRA)

0.1043
0.0000
(0.00%)
As of April 17 at 4:00:00 PM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
7,982.0820
7,982.0820
5,515.1440
5,617.7060
1,409.9760
Cost of Revenue
6,329.1190
6,329.1190
4,103.2440
4,555.9240
979.6220
Gross Profit
1,652.9630
1,652.9630
1,411.9000
1,061.7820
430.3540
Operating Expense
5,417.8480
5,417.8480
4,299.4990
3,151.4770
433.6340
Operating Income
-3,764.8850
-3,764.8850
-2,887.5990
-2,089.6950
-3.2800
Net Non Operating Interest Income Expense
5.6470
5.6470
-50.7440
-28.4700
--
Pretax Income
-3,759.2380
-3,759.2380
-2,938.3430
-2,118.1650
-3.2800
Net Income Common Stockholders
-3,759.2380
-3,759.2380
-2,938.3430
-2,118.1650
-3.2800
Diluted NI Available to Com Stockholders
-3,759.2380
-3,759.2380
-2,938.3430
-2,118.1650
-3.2800
Basic EPS
-0.50
--
-0.60
-0.36
-0.00
Diluted EPS
-0.50
--
-0.60
-0.36
-0.00
Basic Average Shares
7,551.5760
--
4,877.8610
5,860.4360
7,282.5000
Diluted Average Shares
7,551.5760
--
4,877.8610
7,282.5000
7,282.5000
Total Operating Income as Reported
-3,764.8850
-3,764.8850
-2,887.5990
-2,089.6950
-3.2800
Rent Expense Supplemental
142.7250
142.7250
117.8160
107.0130
31.9920
Total Expenses
11,746.9670
11,746.9670
8,402.7430
7,707.4010
1,413.2560
Net Income from Continuing & Discontinued Operation
-3,759.2380
-3,759.2380
-2,938.3430
-2,118.1650
-3.2800
Normalized Income
-3,759.2380
-3,759.2380
-2,938.3430
-2,118.1650
-3.2800
Interest Income
21.2470
21.2470
2.9420
0.0630
--
Interest Expense
15.6000
15.6000
53.6860
28.5330
--
Net Interest Income
5.6470
5.6470
-50.7440
-28.4700
--
EBIT
-3,743.6380
-3,743.6380
-2,884.6570
-2,089.6320
-3.2800
EBITDA
-3,680.9000
-3,680.9000
-2,835.8860
-2,074.7830
-3.0730
Reconciled Cost of Revenue
6,329.1190
6,329.1190
4,103.2440
4,555.9240
979.6220
Reconciled Depreciation
62.7380
62.7380
48.7710
14.8490
0.2070
Net Income from Continuing Operation Net Minority Interest
-3,759.2380
-3,759.2380
-2,938.3430
-2,118.1650
-3.2800
Normalized EBITDA
-3,680.9000
-3,680.9000
-2,835.8860
-2,074.7830
-3.0730
12/31/2021 - 9/29/2023

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

NIVF NewGenIvf Group Limited
0.3169
-1.77%
 
CYH Community Health Systems, Inc.
2.4850
+3.11%
 
INNV InnovAge Holding Corp.
3.0500
+10.51%
 
AGL agilon health, inc.
4.0450
+0.12%
 
TOI The Oncology Institute, Inc.
2.7600
+1.85%
 
NUTX Nutex Health Inc.
148.00
+1.37%
 
NIVFW NewGenIvf Group Limited
0.0131
-7.75%
 
PIIIW P3 Health Partners Inc.
0.0112
+4.67%
 
IONM Assure Holdings Corp.
0.0001
0.00%
 
CMPS COMPASS Pathways plc
3.7550
+5.17%